Of all human tools and inventions, few are as essential, complicated and stigmatized as money. In particular, financial technologies and concepts have often spurred growth, investment and powerful advancements around the globe.
The race to discover CRISPR was one of the great science and business tales of the 21st century, a cross-continent battle of discovery and speed. So how did CRISPR arrive? And more importantly, where might it take us?
By now we know what went wrong in the response to the most devastating pandemic in a century. This is the untold business and science story of what went right.
CD&R Co-President Dave Novak hosts Professor Nien-hê Hsieh, the Joseph L. Rice, III Faculty Fellow at Harvard Business School, for a discussion about the cultural shifts around business and purpose.
Today we explore entrepreneurialism – the spirit that drives it, and what it takes to turn that spiritual drive into tangible action. The journey takes us to hallowed halls at…
Everywhere one turns, trust seems to be crumbling – institutions, politicians, media, even science. Given the current state of trust, what are brands supposed to do? What are the key trends around the building — and breaking — of consumer trust?
Just as business finds solutions to various problems and hurdles, mathematical formulas and practices make sense of our chaotic world. What can business-minded individuals learn from these insights? How do principles of randomness and probability factor into shrewd business planning?
In the time of an unprecedented global pandemic, boards – private and public – have been forced to re-examine priorities. And it’s not just trying to manage through Covid. ESG,…
Has there been a time when science has played a more significant, more direct role in the quality, if not quantity, of our lives?